Sol Total Operating Expenses from 2010 to 2026
| SLGL Stock | USD 84.99 3.34 4.09% |
Total Operating Expenses | First Reported 2015-12-31 | Previous Quarter 6 M | Current Value 6.7 M | Quarterly Volatility 4.9 M |
Review Sol Gel financial statements over time to add context on performance and capital structure. It connects Depreciation And Amortization of 254.6 K, Interest Expense of 1.6 M or Selling General Administrative of 6.8 M and ratios such as Price To Sales Ratio of 24.53, Dividend Yield of 0.0 or PTB Ratio of 8.49 with Sol Gel Valuation and Volatility context.
Sol | Total Operating Expenses | Build AI portfolio with Sol Stock |
Historical Total Operating Expenses data for Sol Gel serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Sol Gel Technologies represents a compelling investment opportunity.
Latest Sol Gel's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Sol Gel Technologies over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Sol Gel's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sol Gel's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Sol Total Operating Expenses Regression Statistics
| Arithmetic Mean | 17,884,550 | |
| Geometric Mean | 12,799,995 | |
| Coefficient Of Variation | 79.55 | |
| Mean Deviation | 12,303,994 | |
| Median | 9,647,000 | |
| Standard Deviation | 14,227,453 | |
| Sample Variance | 202.4T | |
| Range | 44M | |
| R-Value | 0.42 | |
| Mean Square Error | 177.4T | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | 1,190,620 | |
| Total Sum of Squares | 3238.7T |
Sol Total Operating Expenses History
Is Sol Gel Overvalued or Undervalued?
Sol Gel is a micro-cap equity in Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care categories. Intrinsic value assumptions are benchmarked against sector averages. We review the company from a portfolio-construction standpoint emphasizing diversification and stability.
Methodology
Unless otherwise specified, financial data for Sol Gel Technologies is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Sol (USA Stocks:SLGL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Sol Gel Technologies may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetMore Resources for Sol Stock Analysis
A structured review of Sol Gel Technologies often starts with core financial statements and trend context. Ratios and trend metrics help frame Sol Gel's operating context. Key reports that frame Sol Gel Technologies Stock are listed below:Review Sol Gel Correlation against competitors for Sol Gel. This provides competitive positioning context. Analysis related to Sol Gel should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Quarterly Earnings Growth 4.876 | Earnings Share -1.22 | Revenue Per Share | Quarterly Revenue Growth 2.177 | Return On Assets |
The market value of Sol Gel Technologies is measured differently than book value, which reflects Sol accounting equity. Intrinsic value is an analytical estimate of Sol Gel's underlying worth that can differ from price and book value. Prices respond to market conditions and behavior, which can widen gaps versus fundamentals. Valuation methods help interpret those gaps.
Note that Sol Gel's intrinsic value and market price are different measures derived from different inputs. A full view may include fundamental ratios, momentum patterns, industry dynamics, and analyst estimates. Market price reflects the current exchange level formed by active bids and offers.